278 related articles for article (PubMed ID: 27067365)
21. Predictive factors of overall functioning improvement in patients with chronic schizophrenia and schizoaffective disorder treated with paliperidone palmitate and aripiprazole monohydrate.
Girardi P; Del Casale A; Rapinesi C; Kotzalidis GD; Splendori F; Verzura C; Trovini G; Sorice S; Carrus D; Mancinelli I; Comparelli A; De Filippis S; Francomano A; Ballerini A; Marcellusi A; Mennini FS; Ducci G; Sani G; Pompili M; Brugnoli R
Hum Psychopharmacol; 2018 May; 33(3):e2658. PubMed ID: 29766576
[TBL] [Abstract][Full Text] [Related]
22. Response Surface Analysis and Nonlinear Optimization Algorithm for Maximization of Clinical Drug Performance: Application to Extended-Release and Long-Acting Injectable Paliperidone.
Gomeni R; Bressolle-Gomeni F; Fava M
J Clin Pharmacol; 2016 Oct; 56(10):1296-306. PubMed ID: 26899406
[TBL] [Abstract][Full Text] [Related]
23. Serum Concentration of Paliperidone Palmitate Administered Every 3 Weeks.
Cohen JY; Dumoulin-Charette A; Meraabi N; Poirier R
Psychopharmacol Bull; 2019 Jun; 49(2):57-62. PubMed ID: 31308584
[TBL] [Abstract][Full Text] [Related]
24. [Clinical pharmacokinetics and pharmaceutical forms of long-acting injectable antipsychotics].
Kyziridis TC
Psychiatriki; 2022 Jun; 33(2):139-148. PubMed ID: 34390562
[TBL] [Abstract][Full Text] [Related]
25. A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia.
Li H; Rui Q; Ning X; Xu H; Gu N
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1002-8. PubMed ID: 21315787
[TBL] [Abstract][Full Text] [Related]
26. Impact of age and gender on paliperidone exposure in patients after administration of long-acting injectable formulations-an observational study using blood samples from 1223 patients.
Tveito M; Høiseth G; Haslemo T; Molden E; Smith RL
Eur J Clin Pharmacol; 2021 Aug; 77(8):1201-1208. PubMed ID: 33616704
[TBL] [Abstract][Full Text] [Related]
27. Accelerated reactive dissolution model of drug release from long-acting injectable formulations.
Sonntag E; Kolář J; Djukaj S; Lehocký R; Štěpánek F
Eur J Pharm Biopharm; 2023 Aug; 189():122-132. PubMed ID: 37321329
[TBL] [Abstract][Full Text] [Related]
28. Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics.
Pilon D; Tandon N; Lafeuille MH; Kamstra R; Emond B; Lefebvre P; Joshi K
Clin Ther; 2017 Oct; 39(10):1972-1985.e2. PubMed ID: 28919292
[TBL] [Abstract][Full Text] [Related]
29. Critical appraisal of 3-monthly paliperidone depot injections in the treatment of schizophrenia.
Carpiniello B; Pinna F
Drug Des Devel Ther; 2016; 10():1731-42. PubMed ID: 27307704
[TBL] [Abstract][Full Text] [Related]
30. Hospitalizations and economic analysis in psychotic patients with paliperidone palmitate long-acting injection.
Mesones-Peral JE; Gurillo-Muñoz P; Sánchez-Sicilia MP; Miller A; Griñant-Fernández A
Rev Psiquiatr Salud Ment; 2017; 10(1):33-37. PubMed ID: 27053545
[TBL] [Abstract][Full Text] [Related]
31. A quantitative systems pharmacology study on optimal scenarios for switching to paliperidone palmitate once-monthly.
Geerts H; Spiros A; Roberts P; Alphs L
Schizophr Res; 2018 Jul; 197():261-268. PubMed ID: 29395607
[TBL] [Abstract][Full Text] [Related]
32. Recovery outcomes of schizophrenia patients treated with paliperidone palmitate in a community setting: patient and provider perspectives on recovery.
Williams W; McKinney C; Martinez L; Benson C
J Med Econ; 2016; 19(5):469-76. PubMed ID: 26671481
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness and Predictors of Continuation of Paliperidone Palmitate Long-Acting Injection Treatment: A 12-Month Naturalistic Cohort Study.
Whale R; Pereira M; Cuthbert S; Fialho R
J Clin Psychopharmacol; 2015 Oct; 35(5):591-5. PubMed ID: 26267419
[TBL] [Abstract][Full Text] [Related]
34. Paliperidone Palmitate Long-Acting Injectable Given Intramuscularly in the Deltoid Versus the Gluteal Muscle: Are They Therapeutically Equivalent?
Yin J; Collier AC; Barr AM; Honer WG; Procyshyn RM
J Clin Psychopharmacol; 2015 Aug; 35(4):447-9. PubMed ID: 26061612
[TBL] [Abstract][Full Text] [Related]
35. Pharmacoeconomics of depot antipsychotics for treating chronic schizophrenia in Sweden.
Einarson TR; Vicente C; Zilbershtein R; Piwko C; Bø CN; Pudas H; Jensen R; Hemels ME
Nord J Psychiatry; 2014 Aug; 68(6):416-27. PubMed ID: 24274837
[TBL] [Abstract][Full Text] [Related]
36. Single- and multiple-dose pharmacokinetic, safety, and tolerability profiles of olanzapine long-acting injection: an open-label, multicenter, nonrandomized study in patients with schizophrenia.
Mitchell M; Kothare P; Bergstrom R; Zhao F; Jen KY; Walker D; Johnson J; McDonnell D
Clin Ther; 2013 Dec; 35(12):1890-908. PubMed ID: 24184052
[TBL] [Abstract][Full Text] [Related]
37. Going the distance: reviewing antipsychotic depot or long-acting injectable treatments in Australasia.
Theodoros T; Taylor M; Huang HC; Wang N; Motamarri B
Australas Psychiatry; 2018 Jun; 26(3):303-306. PubMed ID: 29457473
[TBL] [Abstract][Full Text] [Related]
38. Effects of Long-Acting Injectable Paliperidone Palmitate on Clinical and Functional Outcomes in Patients With Schizophrenia Based on Illness Duration.
Kim S; Kim S; Koh M; Choi G; Kim JJ; Paik IH; Kim SH; Choi YS; Lee Y; Suh J; Takeuchi H; Uchida H; Kim E
J Clin Psychiatry; 2021 Jan; 82(1):. PubMed ID: 33434958
[TBL] [Abstract][Full Text] [Related]
39. Multimodal imaging approach to examine biodistribution kinetics of Cabotegravir (GSK1265744) long acting parenteral formulation in rat.
Jucker BM; Alsaid H; Rambo M; Lenhard SC; Hoang B; Xie F; Groseclose MR; Castellino S; Damian V; Bowers G; Gupta M
J Control Release; 2017 Dec; 268():102-112. PubMed ID: 29042321
[TBL] [Abstract][Full Text] [Related]
40. Does Half-Life Matter After Antipsychotic Discontinuation? A Relapse Comparison in Schizophrenia With 3 Different Formulations of Paliperidone.
Weiden PJ; Kim E; Bermak J; Turkoz I; Gopal S; Berwaerts J
J Clin Psychiatry; 2017 Jul; 78(7):e813-e820. PubMed ID: 28640988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
